Univac

Univac is rated 3 out of 5 in the category biotechnology. Read and write reviews about Univac. Univac is a preclinical-stage biotechnology start-up that develops NK-cells directed vaccines and immune therapies. By targeting unconventional antigens and activating Natural Killer cells, Univac has discovered a new transformative approach that allows development of universally protective vaccines that prevent or cure a broad range of acute viral infections and immune-mediated (allergies and immune inflammatory diseases) or tumour diseases. Univac vaccines have the potential to meet medical needs for which vaccines or treatments do not exist or, where available, are very expensive.